Breast cancer is the most common type of malignant cancer prevalent in women above the age of 40. According to the estimates of World Health Organization, cancer is the most fatal human disease accounting for the deaths of ~8.2 million people worldwide in 2012. Among these deaths, breast cancer was found to be most prominent disease among women that killed ~521,000 individuals. Presently, increasing number of hormone therapies have made refractory breast cancers resistant toward therapeutics, termed as hormone-resistant breast cancers. However, recently developed hormone refractory breast cancer chemotherapeutic agents such as, trastuzumab and everolimus, alone or in combination, are under clinical trials for the effective treatment of hormone refractory breast cancers.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
- F. Hoffmann La Roche Ltd,
- AstraZeneca,
- Bluefish Pharmaceuticals AB,
- Boehringer Ingelheim International GmbH
- Neopharm Group,
- Novartis AG,
- Eli Lilly and Company,
- Teva Pharmaceutical Industries Ltd,
- Mylan N.V.,
- Amneal Pharmaceuticals LLC
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-toc-and-sample/1212
๐๐๐ญ ๐๐ฉ ๐๐จ ๐๐% ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ, ๐๐ข๐ฅ๐ฅ ๐ญ๐ก๐ ๐๐๐ญ๐ ๐๐๐ญ๐ก ๐จ๐ ๐๐ฎ๐ ๐ฎ๐ฌ๐ญ ๐๐๐๐.
Key factors responsible for the growth of this market involve increasing incidences of breast cancers, aging population, demands of advanced therapeutics, increasing prevalence of hormone refractory breast cancers, and the presence of a significant number of anticancer pipeline drugs. Rising life span of cancer-affected population is one of the other factors responsible for the growth of this market. However, social stigma of testing breast cancer lacks technological reach. Insufficient advanced chemotherapeutic treatments restraining the hormone refractory breast cancer market. Substantial number of new chemical entities (NCEs) in various phases of clinical trials will emerge as potential opportunities in the Asia Pacific market.
The Asia Pacific hormone refractory breast cancer market is segmented into China, Japan, India, Australia and others. The Asia-Pacific region is expected to rise at the significant pace, owing to rapid growth of pharmaceutical and healthcare industry along with the improved purchasing power of the service providers in this region. Rapidly emerging economies and the rise of medical tourism in regions such as India and China, will drive the growth of hormone refractory breast cancer market. Rising kidney failure, prevalence rates, in the Asia-Pacific regions should boost the growth of this market.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/1212
๐๐๐ ๐
๐๐๐๐๐๐๐ ๐๐
๐๐๐ ๐๐๐๐๐
- The analysis, made in this report, helps in understanding the strategies adopted by various companies for gaining market share in hormone refractory breast cancer market
- This report provides a comprehensive analysis of factors that drive and restrict the growth of the hormone refractory breast cancer market
- Detailed study of the strategies of key leaders, partnerships, and acquisitions in the Asia Pacific hormone refractory breast cancer market would be informative for professionals in the corporate sector
- Pin-point analysis of geographic segments helps to identify opportunities for growth within the hormone refractory breast cancer market
- An analysis for the market attractiveness has been included for therapeutics, devices, and geographic regions along with a detailed analysis of factors responsible for the rapid growth of the market segments
- Ease of doing business analysis should help in making strategic business decisions
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
Veterinary Point of Care Blood Gas Analyzers Market
๐๐ฅ๐ฌ๐จ ๐๐๐๐ ๐๐ฒ ๐๐ฅ๐จ๐ ๐ฌ
Singapore Latex Foley Catheters Market
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com